미국의 외래 수술 센터 시장 규모, 점유율, 동향 분석 리포트 : 전문별, 소유별, 센터 유형별, 기기 유형별, 지역별, 부문별 예측(2024-2030년)

U.S. Ambulatory Surgery Center Market Growth & Trends:

The U.S. ambulatory surgery center market and U.S. ambulatory surgery center devices market size is expected to reach USD 60.8 billion and USD 49.1 billion by 2030 expanding at a CAGR of 6.02% and CAGR 8.89% from 2024 to 2030, based on a new report by Grand View Research, Inc. The market's growth can be attributed to the reduced healthcare costs in ASCs, favorable reimbursement rates for ASCs, and a decreased risk of infection compared to hospitals.

Moreover, recently experienced notable technological advancements, prioritizing enhancing patient outcomes, cost reduction, and operational efficiency. The increasing utilization of robotics and 3D printing technology has empowered surgeons to conduct procedures with greater precision and less invasiveness, leading to swifter recovery periods and improved patient results. For instance, in July 2023, Stryker launched the Ortho Q guidance system, a robotics-ready platform.

The system has a small footprint and is designed for use in ASCs and operating rooms. Over the last decade, the demand for ASCs has increased, especially for multispecialty ASCs. This is attributed to a rise in the number of surgical procedures due to the high burden of chronic diseases in the U.S. According to ASC Data, as of Q4 2023, there were 3,072 multispecialty ASCs in the U.S. Multispecialty ASCs have the advantage of providing a wide array of quality services, competing well with hospital-owned ASCs.

U.S. Ambulatory Surgery Center Market Report Highlights:

• On the basis of specialty, the orthopedics segment held the largest share in 2023 due to the expansion of new procedures falling under ASC coverage, coupled with advancements in diagnostic techniques and imaging technologies within orthopedic surgeries
• On the basis of ownership, the physician-owned segment dominated the market in 2023 owing to advantages linked to it including the presence of proficient physicians and their convenient accessibility
• The single-specialty center type segment dominated the market with the largest revenue share in 2023 owing to the presence of a large number of single-specialty ASCs across the country
• The southeast region dominated the market in 2023 owing to the high popularity of outpatient surgery and a considerable number of ASCs owned by physicians in the region
• The orthopedic device type segment dominated the market in 2023. This can be attributed to the shift of orthopedic procedures to outpatient centers
• In November 2023, BD launched an advanced ultrasound system to help clinicians with the placement of Peripherally Inserted Central Catheters (PICCs), IV lines, central venous catheters, and other vascular access devices. This system is developed to improve clinician efficiency and make the process smoother

Table of Contents

Chapter 1 U.S. Ambulatory Surgery Center Market: Report Scope & Research Methodology

• 1.1 Market Segmentation
  • 1.1.1 Segment Definition
    • 1.1.1.1 Application
    • 1.1.1.2 Ownership
    • 1.1.1.3 Center Type
    • 1.1.1.4 Device Type
    • 1.1.1.5 Region
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information procurement
  • 1.3.2 Purchased Database
  • 1.3.3 GVR's Internal Database
  • 1.3.4 Secondary Sources
  • 1.3.5 Primary Research
  • 1.3.6 Details of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
  • 1.5.1 Commodity Flow Analysis
• 1.6 List of Secondary Sources
• 1.7 List of Abbreviations

Chapter 2 U.S. Ambulatory Surgery Center Market: Research Objectives

• 2.1 Objective - 1
• 2.2 Objective - 2
• 2.3 Objective - 3

Chapter 3 U.S. Ambulatory Surgery Center Market: Executive Summary

• 3.1 Market Snapshot
• 3.2 Segment Outlook
• 3.3 Competitive Scenario

Chapter 4. Specialty Business Analysis

• 4.1. U.S. Ambulatory Surgery Center Market: Specialty Movement Analysis
• 4.2. U.S. Ambulatory Surgery Center Market: Specialty Segment Dashboard
• 4.3. Specialty Movement & Market Share Analysis, 2023 & 2030
• 4.4. U.S. Ambulatory Surgery Center Market Estimates & Forecast, by Specialty
• 4.5. Orthopedics
  • 4.5.1. Orthopedics market, 2018 - 2030 (USD Billion)
• 4.6. Pain Management/Spinal Injections
  • 4.6.1. Pain Management/Spinal Injections market, 2018 - 2030 (USD Billion)
• 4.7. Gastroenterology
  • 4.7.1. Gastroenterology market, 2018 - 2030 (USD Billion)
• 4.8. Ophthalmology
  • 4.8.1. Ophthalmology market, 2018 - 2030 (USD Billion)
• 4.9. Plastic Surgery
  • 4.9.1. Plastic Surgery market, 2018 - 2030 (USD Billion)
• 4.10. Otolaryngology
  • 4.10.1. Otolaryngology market, 2018 - 2030 (USD Billion)
• 4.11. Obstetrics/Gynecology
  • 4.11.1. Obstetrics/Gynecology market, 2018 - 2030 (USD Billion)
• 4.12. Dental
  • 4.12.1. Dental market, 2018 - 2030 (USD Billion)
• 4.13. Podiatry
  • 4.13.1. Podiatry market, 2018 - 2030 (USD Billion)
• 4.14. Cardiology
  • 4.14.1. Cardiology market, 2018 - 2030 (USD Billion)
• 4.15. Respiratory
  • 4.15.1. Respiratory market, 2018 - 2030 (USD Billion)
• 4.16. Others
  • 4.16.1. Others market, 2018 - 2030 (USD Billion)

Chapter 5. Ownership Business Analysis

• 5.1. U.S. Ambulatory Surgery Center Market: Ownership Movement Analysis
• 5.2. U.S. Ambulatory Surgery Center Market: Ownership Segment Dashboard
• 5.3. Ownership Movement & Market Share Analysis, 2023 & 2030
• 5.4. U.S. Ambulatory Surgery Center Market Estimates & Forecast, by Ownership
• 5.5. Physician Owned
  • 5.5.1. Physician owned market, 2018 - 2030 (USD Billion)
• 5.6. Hospital Owned
  • 5.6.1. Hospital owned market, 2018 - 2030 (USD Billion)
• 5.7. Corporate Owned
  • 5.7.1. Corporate owned market, 2018 - 2030 (USD Billion)

Chapter 6. Center Type Business Analysis

• 6.1. U.S. Ambulatory Surgery Center Market: Center Type Movement Analysis
• 6.2. U.S. Ambulatory Surgery Center Market: Center Type Segment Dashboard
• 6.3. Center Type Movement & Market Share Analysis, 2023 & 2030
• 6.4. U.S. Ambulatory Surgery Center Market Estimates & Forecast, by Center Type
• 6.5. Single-specialty
  • 6.5.1. Single-specialty market, 2018 - 2030 (USD Billion)
• 6.6. Multi-specialty
  • 6.6.1. Multi-specialty market, 2018 - 2030 (USD Billion)

Chapter 7. Region Business Analysis

• 7.1. U.S. Ambulatory Surgery Center Market: Region Movement Analysis
• 7.2. U.S. Ambulatory Surgery Center Market: Region Segment Dashboard
• 7.3. Region Movement & Market Share Analysis, 2023 & 2030
• 7.4. U.S. Ambulatory Surgery Center Market Estimates & Forecast, by Region
• 7.5. Southeast
  • 7.5.1. Southeast market, 2018 - 2030 (USD Billion)
• 7.6. West
  • 7.6.1. West market, 2018 - 2030 (USD Billion)
• 7.7. Midwest
  • 7.7.1. Midwest market, 2018 - 2030 (USD Billion)
• 7.8. Northeast
  • 7.8.1. Northeast market, 2018 - 2030 (USD Billion)
• 7.9. Southwest
  • 7.9.1. Southwest market, 2018 - 2030 (USD Billion)

Chapter 8. Device Type Business Analysis

• 8.1. U.S. Ambulatory Surgery Center Market: Device Type Movement Analysis
• 8.2. U.S. Ambulatory Surgery Center Market: Device Type Segment Dashboard
• 8.3. Device Type Movement & Market Share Analysis, 2023 & 2030
• 8.4. U.S. Ambulatory Surgery Center Market Estimates & Forecast, by Device Type
• 8.5. Orthopedic
  • 8.5.1. Orthopedic market, 2018 - 2030 (USD Billion)
• 8.6. Gastroenterology
  • 8.6.1. Gastroenterology market, 2018 - 2030 (USD Billion)
• 8.7. Ophthalmology
  • 8.7.1. Ophthalmology market, 2018 - 2030 (USD Billion)
• 8.8. Dermatology
  • 8.8.1. Dermatology market, 2018 - 2030 (USD Billion)
• 8.9. Pain Management
  • 8.9.1. Pain Management market, 2018 - 2030 (USD Billion)
• 8.10. Cardiology
  • 8.10.1. Cardiology market, 2018 - 2030 (USD Billion)
• 8.11. Respiratory
  • 8.11.1. Respiratory market, 2018 - 2030 (USD Billion)
• 8.12. Others
  • 8.12.1. Others market, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Company Market Position Analysis
• 9.3. Strategy Mapping
  • 9.3.1. Partnership/Collaboration/Alliance
  • 9.3.2. New Service Launch
  • 9.3.3. Mergers & Acquisitions
  • 9.3.4. Others
• 9.4. Company Profiles/Listing: Service Providers
  • 9.4.1. Envision Healthcare Corporation (KKR & CO. INC.)
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Service benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Tenet Healthcare Corporation
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Service benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Mednax Services, Inc. (Pediatrix Medical Group, Inc)
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Service benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. TeamHealth
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Service benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. UnitedHealth Group
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Service benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Quorum Health
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Service benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Surgery Partners
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Service benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Community Health Systems, Inc.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Service benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. SurgCenter
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Service benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Prospect Medical Systems
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Service benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Edward-Elmhurst Health
    • 9.4.11.1. Overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Service benchmarking
    • 9.4.11.4. Strategic initiatives
• 9.5. Company Profiles/Listing: Manufacturers
  • 9.5.1. MCKESSON CORPORATION
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Service benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. BD
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Service benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Koninklijke Philips N.V.
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Service benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. 3M
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Service benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. Olympus America
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Service benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. GE HealthCare
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Service benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Abbott
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Service benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Medtronic
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Service benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Zimmer Biomet
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Service benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Henry Schein, Inc.
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Service benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. STERIS plc
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Service benchmarking
    • 9.5.11.4. Strategic initiatives